Tom Feys MBA, MSc

The American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2013

Summary

From the 24^th till the 26^th of January, San Francisco was the setting for the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2013. The meeting, cosponsored by ASCO, ASTRO and SSO, again focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of gastrointestinal (GI) cancers.

(BELG J MED ONCOL 2013;7(2):57–59)

New Oncology reimbursements in Belgium

(BELG J MED ONCOL 2013;7:34)

The 35^th San Antonio Breast Cancer Symposium

Summary

From December 4^th-8^th 2012, San Antonio, Texas, was again transformed into the world’s capital in the fight against breast cancer. The 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) was a joint presentation of the Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio, the American Association for Cancer Research, and the Baylor College of Medicine. This years’ meeting drew nearly 8,000 participants from over 90 countries and again proved to be the number one breast cancer meeting in the world. This report does not aim to summarise the entire meeting but discusses the key highlights of the meeting.

(BELG J MED ONCOL 2013;7:31–33)

Highlights in Oncology 2012

Summary

2012 has been a rich year in progress on cancer care. Many studies highlighted this year capitalised on the growing insight into the complexity of cancer to develop sophisticated treatment approaches, including combinations of targeted drugs for difficult-to-treat cancers and expanded use of targeted drugs to multiple forms of cancer sharing the same genetic alteration. This article is based on the clinical cancer advances 2012 article published by the American Society of Clinical Oncology and lists the most important advances made in the different fields of oncology that are most likely to impact daily clinical practice.¹

(BELG J MED ONCOL 2013;7:10–14)

New oncology reimbursements in Belgium

Overview of Belgian reimbursement news. (BELG J MED ONCOL 2012;6:212–213)

The 6th Belgian symposium on the integration of molecular biology advances into oncology clinical practice

On the 23^rd and 24^th of November 2012, the Jules Bordet Institute and the Belgian Society of Medical Oncology (BSMO) hosted the 6^th Belgian symposium on the integration of molecular biology advances into oncology clinical practice. The aim of this meeting once more was to translate the major advances made in molecular and biological understanding in cancer into clear messages for daily oncological, clinical practice. Over the two days, a plethora of Belgian and international key opinion leaders discussed the clinical impact of molecular advances in several tumour types. Given the high quality of the different lectures, it was not surprising to see that the meeting again obtained the ESMO label. (BELG J MED ONCOL 2012;6:207–211)

New oncology reimbursements in Belgium

New oncology reimbursements in Belgium.
(BELG J MED ONCOL 2012;6:181–182)